Skip to main content
. 2023 Nov 9;21:319. doi: 10.1186/s12964-023-01320-z

Fig. 3.

Fig. 3

USP7 inhibitor upregulated c-Myc in cancer cells via USP22-dependent way. Western blot analysis of elevated c-Myc in A. A549 and B. HCT116 cancer cells treated with defined amounts of FT671 for 72h. C. FT671 treatment increased c-Myc-responsive luciferase reporter activity in H1299 cells in a dose-dependent manner, *p<0.05, ** p<0.01, compared to 0 (Vehicle). D. Western blot analysis of FT671-induced c-Myc in the parental (Wt) and USP22-Ko (Ko) H1299 cancer cells